LEADER 01682nas  2200589-a 450 
001 996217952703316
005 20230908213017.0
011   $a2164-554X
035   $a(DE-599)ZDB2664177-X
035   $a(OCoLC)759857116
035   $a(CKB)2550000000071514
035   $a(CONSER)--2011202529
035   $a(EXLCZ)992550000000071514
100   $a20111107a20129999  s--            a
101 0 $aeng
135   $aur|||||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aHuman vaccines & immunotherapeutics
210  1$a[Austin, Tex.] :$cLandes Bioscience,$d[2012]-
210 31$a[New York, NY] :$cTaylor & Francis
210  4$dİ2012-
215   $a1 online resource
300   $aRefereed/Peer-reviewed
311   $a2164-5515 
517 1 $aHuman vaccines and immunotherapeutics
517 1 $aHV&I
531   $aHUM VACCIN IMMUNOTHER
531   $aHUMAN VACCINES IMMUNOTHER
531   $aHUM VACC IMMUNOTHER
531 0 $aHum. vaccin. immunother.
606   $aVaccines$vPeriodicals
606   $aImmunotherapy$vPeriodicals
606   $aVaccines
606   $aImmunotherapy
606   $aImmunotherapy$2fast$3(OCoLC)fst00968044
606   $aVaccines$2fast$3(OCoLC)fst01163573
608   $aPeriodicals.$2lcgft
608   $aPeriodical.
608   $aPeriodicals.$2fast
615  0$aVaccines
615  0$aImmunotherapy
615  2$aVaccines.
615  2$aImmunotherapy.
615  7$aImmunotherapy.
615  7$aVaccines.
676   $a614.4
906   $aJOURNAL
912   $a996217952703316
996   $aHuman vaccines & immunotherapeutics$92016945
997   $aUNISA